Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4862140
Max Phase: Preclinical
Molecular Formula: C51H82N16O12
Molecular Weight: 1111.32
Molecule Type: Unknown
Associated Items:
ID: ALA4862140
Max Phase: Preclinical
Molecular Formula: C51H82N16O12
Molecular Weight: 1111.32
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C51H82N16O12/c1-30(2)27-39(47(77)62-36(10-7-25-58-49(55)56)45(75)64-38(43(54)73)28-31-12-16-33(68)17-13-31)65-46(76)37(11-8-26-59-50(57)67-51(79)60-24-6-5-23-53)63-48(78)40(29-32-14-18-34(69)19-15-32)66-44(74)35(9-3-4-22-52)61-41(70)20-21-42(71)72/h12-19,30,35-40,68-69H,3-11,20-29,52-53H2,1-2H3,(H2,54,73)(H,61,70)(H,62,77)(H,63,78)(H,64,75)(H,65,76)(H,66,74)(H,71,72)(H4,55,56,58)(H4,57,59,60,67,79)/t35-,36-,37-,38-,39-,40-/m0/s1
Standard InChI Key: GZJIPUXBBMCZCH-UNHORJANSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1111.32 | Molecular Weight (Monoisotopic): 1110.6298 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):